These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38374356)

  • 1. The involvement of serotonin in major depression: nescience in disguise?
    Arnone D; Wise T; Fitzgerald PB; Harmer CJ
    Mol Psychiatry; 2024 Jan; 29(1):200-202. PubMed ID: 38374356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of amitriptyline on the metabolism of catecholamines and serotonin in depressed patients].
    Bruno A; Cumer Bruno S
    Riv Neurobiol; 1969; 15(4):749-61. PubMed ID: 5403687
    [No Abstract]   [Full Text] [Related]  

  • 3. Major depression as a disorder of serotonin resistance: inference from diabetes mellitus type II.
    Smolin B; Klein E; Levy Y; Ben-Shachar D
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):839-50. PubMed ID: 17250776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythm of salivary serotonin in patients with major depressive disorder.
    Tan ZL; Bao AM; Tao M; Liu YJ; Zhou JN
    Neuro Endocrinol Lett; 2007 Aug; 28(4):395-400. PubMed ID: 17693970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
    Fakhoury M
    Mol Neurobiol; 2016 Jul; 53(5):2778-2786. PubMed ID: 25823514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression.
    Kambeitz JP; Howes OD
    J Affect Disord; 2015 Nov; 186():358-66. PubMed ID: 26281039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Depressive Disorder (MDD) is associated with a primary defect within the serotonergic system.
    Perlis M; Smith M; Orff H
    Sleep Med Rev; 2002 Oct; 6(5):353-7; discussion 359. PubMed ID: 12539755
    [No Abstract]   [Full Text] [Related]  

  • 8. P300 event-related potential and serotonin-1A activity in depression.
    Hansenne M; Ansseau M
    Eur Psychiatry; 1999 Jun; 14(3):143-7. PubMed ID: 10572339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease.
    Michelsen KA; Prickaerts J; Steinbusch HW
    Prog Brain Res; 2008; 172():233-64. PubMed ID: 18772036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ
    J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects.
    Borroto-Escuela DO; Ambrogini P; Chruścicka B; Lindskog M; Crespo-Ramirez M; Hernández-Mondragón JC; Perez de la Mora M; Schellekens H; Fuxe K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.
    Martin V; Mathieu L; Diaz J; Salman H; Alterio J; Chevarin C; Lanfumey L; Hamon M; Austin MC; Darmon M; Stockmeier CA; Masson J
    J Psychiatry Neurosci; 2020 Sep; 45(5):344-355. PubMed ID: 32459080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating the serotonin system in the treatment of major depressive disorder.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, serotonin and major depression.
    Catena-Dell'Osso M; Rotella F; Dell'Osso A; Fagiolini A; Marazziti D
    Curr Drug Targets; 2013 May; 14(5):571-7. PubMed ID: 23531160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder.
    Tiger M; Rück C; Forsberg A; Varrone A; Lindefors N; Halldin C; Farde L; Lundberg J
    Psychiatry Res; 2014 Aug; 223(2):164-70. PubMed ID: 24916155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain responses to serotonin in major depressive disorder.
    Anderson AD; Oquendo MA; Parsey RV; Milak MS; Campbell C; Mann JJ
    J Affect Disord; 2004 Nov; 82(3):411-7. PubMed ID: 15555692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and their role in depression.
    Wilson DR; Warise L
    Perspect Psychiatr Care; 2008 Oct; 44(4):285-9. PubMed ID: 18826467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence in major depressive disorder: a neurocognitive perspective.
    Robinson OJ; Sahakian BJ
    Psychol Med; 2008 Mar; 38(3):315-8. PubMed ID: 18298875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.